论文部分内容阅读
Background:Polypoidal choroidal vasculopathy (PCV) is characterized by the presence of polyps with or without a branching vascular network and more prevalent among Asians.The aim of this study was to compare the outcomes of conbercept therapy between two different angiographic subtypes of PCV.Methods:Fifty-eight patients of PCV were classified into two phenotypes according to indocyanine green angiography (ICGA).In Type 1,both feeder and draining vessels are visible on ICGA and network vessels are numerous.In Type 2,neither feeder nor draining vessels are detectable,and the number of network vessels is small.The patients were treated with intravitreal conbercept (IVC) for 3 months.Additional 1VC was given at subsequent monthly visits,if needed.The patients were followed up for 12 months,and changes in mean best-corrected visual acuity (BCVA),central retinal thickness (CRT),subretinal fluid (SRF) thickness,pigmented epithelial detachment (PED),hemorrhage,and number of polypoidal lesions were evaluated.Results:The mean BCVA in Type 2 PCV (15.92 ± 9.76 letters) achieved a significantly greater improvement than that in the Type 1 (14.10± 9.07 letters) at month 12 (t=2.37,P＜ 0.01).Moreover,the mean CRTdecrease was numerically greater in Type 2 (120.44± 73.81μm) compared with Type 1 (106.48 ± 72.33 μm) at month 6 (t =4.31,P ＜ 0.01),and greater in Type 2 (130.21 ± 76.28 μm) compared with Type 1 (111.67 ± 79.57μm) at month 9 (t =1.87,P ＜ 0.0l).There was no significant difference between the two types for the decrease in SRF thickness,PED height,and regression of polyps from month 3 to 12 (t =2.97,P＞ 0.05).Conclusion:Classification systems for PCV will show differences in presentation,natural history,or response to anti-vascular endothelial growth factor treatment and might,therefore,provide a new key to the choice of treatment for the disease.